4//SEC Filing
ATWOOD BRIAN G 4
Accession 0001213900-25-029111
CIK 0001870404other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 7:12 PM ET
Size
9.9 KB
Accession
0001213900-25-029111
Insider Transaction Report
Form 4
ATWOOD BRIAN G
Director
Transactions
- Exercise/Conversion
Pre-Funded Warrant
2025-03-31$0.00/sh+294,460$29→ 11,660 totalExercise: $0.00From: 2025-02-07→ Common Stock (294,460 underlying) - Exercise/Conversion
Common Stock
2025-03-31$0.00/sh+294,460$29→ 490,534 total(indirect: See Footnote)
Holdings
- 1,250
Common Stock
- 204,080(indirect: By LLC)
Pre-Funded Warrant
Exercise: $0.00From: 2025-02-07→ Common Stock (204,080 underlying)
Footnotes (3)
- [F1]On March 28, 2025, Mr. Atwood exercised Pre-Funded Warrants (the "Pre-Funded Warrants") and directed the issuance of the shares of common stock of CERo Therapeutics Holdings, Inc. (the "Issuer") to the Atwood-Edminster Trust dtd 4-2-2000 (the "Trust"). Mr. Atwood and his wife are the managers of the LLC and the trustees of the Trust. Accordingly, Mr. Atwood may be deemed to have beneficial ownership of the securities held directly by the LLC..
- [F2]The Pre-Funded Warrants are exercisable at any time on or after the date of issuance for an exercise price of $0.0001 per share, for shares of common stock of the Issuer.
- [F3]GVN, LLC (the "LLC") is a limited liability company of which the sole member is the Trust..
Documents
Issuer
CERO THERAPEUTICS HOLDINGS, INC.
CIK 0001870404
Entity typeother
Related Parties
1- filerCIK 0001266567
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 7:12 PM ET
- Size
- 9.9 KB